tazicef

Generic: ceftazidime

Labeler: hospira, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tazicef
Generic Name ceftazidime
Labeler hospira, inc.
Dosage Form INJECTION, POWDER, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

ceftazidime 2 g/1

Manufacturer
Hospira, Inc.

Identifiers & Regulatory

Product NDC 0409-5093
Product ID 0409-5093_3f749ee0-db14-4ed0-9056-d545a38bbe3b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA064032
Listing Expiration 2026-12-31
Marketing Start 2006-04-05

Pharmacologic Class

Classes
cephalosporin antibacterial [epc] cephalosporins [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04095093
Hyphenated Format 0409-5093

Supplemental Identifiers

RxCUI
1659283 1659287 1659292 1659294
UNII
9M416Z9QNR

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tazicef (source: ndc)
Generic Name ceftazidime (source: ndc)
Application Number ANDA064032 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 g/1
source: ndc
Packaging
  • 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5093-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5093-14)
source: ndc

Packages (1)

0409-5093-11 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5093-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5093-14)

Ingredients (1)

ceftazidime (2 g/1)

Linked Drug Pages (1)

TAZICEF ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3f749ee0-db14-4ed0-9056-d545a38bbe3b", "openfda": {"unii": ["9M416Z9QNR"], "rxcui": ["1659283", "1659287", "1659292", "1659294"], "spl_set_id": ["9b73979c-c95a-4433-0a9d-f9cea3cb557f"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5093-11)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5093-14)", "package_ndc": "0409-5093-11", "marketing_start_date": "20060405"}], "brand_name": "TAZICEF", "product_id": "0409-5093_3f749ee0-db14-4ed0-9056-d545a38bbe3b", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "0409-5093", "generic_name": "CEFTAZIDIME", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAZICEF", "active_ingredients": [{"name": "CEFTAZIDIME", "strength": "2 g/1"}], "application_number": "ANDA064032", "marketing_category": "ANDA", "marketing_start_date": "20060405", "listing_expiration_date": "20261231"}